DOCSLIB.ORG

List of SARS-Cov-2 Diagnostic Test

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
List of SARS-Cov-2 Diagnostic Test Version 2 8 May 2020 List of SARS-CoV-2 Diagnostic test kits and equipments eligible for procurement according to Board Decision on Additional Support for Country Responses to COVID-19 (GF/B42/EDP11) SARS-CoV-2 Nuclear Acid Amplification Technologies Product codes superscripted with a * (star) mark is WHO prequalified Anticipated Manufacturer Product Product Name Platform Recommended Eligibility Reference detail Manufacturer Detection type Shelf life Specimen type Comments Catalogue number (IVD product) (Extraction and amplification equipement) storage temperature WHO EUL or others (months) 1DROP INC. (imported For consumables E gene and nasopharyng and details of 444213 1COPY COVID-19 QPCR KIT 24T/kit by Luminarie Canada 6 months 15 to 30°C Health Canada/Interim Order RdRp gene eal swabs componants refer Inc.) to IFU For consumables US FDA EUA Abbott Diagnostics nasopharyng and details of 190-000 ID NOW COVID-19 Test Kit 96T/kit ID NOW Instrument RdRp segment see IFU 2 to 30 ºC Health Canada/Interim Order Scarborough Inc eal swabs componants refer to IFU WHO EUL For consumables US FDA EUA Abbott RealTime SARS-CoV-2 RdRp and N and details of Health Canada/Interim Order 09N77-090 96T/kit Abbott m2000 Abbott Molecular see IFU -25 to -15 ºC see IFU RT-PCR Kit genes componants refer TGA to IFU WHO EUL CFX96™ Touch Real- Time PCR Detection AltoStar® System (Bio-Rad) For consumables RealStar® SARS-CoV-2 RT- Altona Diagnostics and details of 821025 384T/kit Automation see IFU -25 to -15 ºC see IFU US FDA EUA PCR Kit U.S. GmbH componants refer System AM16 CFX96™ Touch Deep to IFU Well Real-Time PCR Detection System (BioRad nasal, N gene and nasopharyng For consumables iAMP® COVID-19 Detection CFX96 Real-Time and details of iAMP-COVID19-100 100T/kit not required Atila BioSystems, Inc. the ORF-1ab 12 months lower than -20 ºC eal and US FDA EUA Kit System componants refer gene oropharynge to IFU al swab AusDiagnostics respiratory For consumables AusDiagnostics Pty Ltd and details of virus panel (including SARS- see IFU see IFU see IFU TGA (Australia) componants refer CoV-2) test to IFU nasal, N gene (N1 nasopharyng For consumables Becton, Dickinson and ambient and details of US FDA EUA 445003 BD SARS-CoV-2 Reagents 24T/kit BD MAX™ System and N2 see IFU eal and Company temperature componants refer Health Canada/Interim Order regions) oropharynge to IFU al swab List of SARS-CoV-2 Diagnostic test kits eligible for procurement according to Board Decision GF/B42/EDP11 1/10 SARS-CoV-2 Nuclear Acid Amplification Technologies Product codes superscripted with a * (star) mark is WHO prequalified Anticipated Manufacturer Product Product Name Platform Recommended Eligibility Reference detail Manufacturer Detection type Shelf life Specimen type Comments Catalogue number (IVD product) (Extraction and amplification equipement) storage temperature WHO EUL or others (months) For consumables Becton, Dickinson and nasopharyng and details of 444213 BioGX SARS-CoV-2 Reagents 24T/kit BD MAX™ System 6 months 15 to 30°C US FDA EUA Company eal swabs componants refer to IFU Real-Time Fluorescent RT- QIAamp Virus Applied Biosystems For consumables throat swabs and details of PCR Kit for Detecting SARS- 50T/kit RNA Mini Kit (cat. 7500 Real-Time PCR BGI Genomics Co. Ltd ORF1ab 12 months lower than -18 ºC US FDA EUA or BALF componants refer 2019-nCoV #52904 or 52906). System to IFU 423745 6T/kit For consumables FilmArray® 2.0 and/or the FilmArray® ORF1ab and nasopharyng and details of BioFire® COVID-19 Test BioFire Defense, LLC see IFU 15 to 30°C US FDA EUA Torch Instrument Systems ORF8 eal swabs componants refer 423744 30T/kit to IFU 7500 & 7500 Fast Real- Time PCR System (Applied Biosystems) EMAG® (bioMérieux) QuantStudio12 Flex (QS12) instrument (Applied Biosystems) 30 and For consumables ARGENE® SARS-COV-2 R- 120T/kit N gene and and details of 423735 NucliSENS LightCycler 480 BioMérieux SA see IFU -31 to -15 ºC see IFU US FDA EUA GENE® (depending RdRp gene componants refer easyMAG (System II) on PCR) to IFU (bioMérieux) (Roche) CFX96 Touch Real- QIASymphony SP Time PCR (QIAgen) Detection System (Bio- Rad) MagNA Pure 96 Rotor‑Gene Q (Roche) (Qiagen) ThermoFisher MagMAX™ Viral/Pathogen QX200™ PCR Nucleic Acid Systems Isolation Kit (Cat For consumables 2019-nCoV CDC ddPCR and details of 12008202 200T/kit No. A48310, 1000 BioRad P and N genes see IFU -25 to -15 ºC see IFU US FDA EUA Triplex Probe Assay reactions) componants refer to IFU QIAamp Virus QXDx™ Droplet RNA Mini Kit (cat. Digital™ PCR Systems # 52906) List of SARS-CoV-2 Diagnostic test kits eligible for procurement according to Board Decision GF/B42/EDP11 2/10 SARS-CoV-2 Nuclear Acid Amplification Technologies Product codes superscripted with a * (star) mark is WHO prequalified Anticipated Manufacturer Product Product Name Platform Recommended Eligibility Reference detail Manufacturer Detection type Shelf life Specimen type Comments Catalogue number (IVD product) (Extraction and amplification equipement) storage temperature WHO EUL or others (months) GeneXpert Dx For consumables US FDA EUA Genes N2 and and details of XPRSARS-COV2-10 Xpert® Xpress SARS-CoV-2 10T/kit GeneXpert Infinity Systems Cepheid see IFU 2 to 28°C see IFU Health Canada/Interim Order E componants refer to IFU TGA GeneXpert Xpress System (Tablet and Hub Configurations) For consumables VIASURE SARS-CoV-2 Real CerTest Biotec SL / nasopharyng and details of see IFU see IFU TGA Time PCR Detection Kit Abacus dx eal swabs componants refer to IFU For consumables VIASURE SARS-CoV-2 S gene CerTest Biotec SL / nasopharyng and details of see IFU see IFU TGA Real Time PCR Detection Kit Becton Dickinson eal swabs componants refer to IFU QIAamp Virus For consumables LOGIX SMART™ Coronavirus CoDx Box (BMS, Bio nasopharyng and details of COVID-K-001 100T/kit RNA Mini Kit Co-Diagnostics, Inc 12 months lower than -20 ºC US FDA EUA Disease 2019 (COVID-19) Kit Molecular Systems) eal swabs componants refer (Qiagen) to IFU Applied Biosystems™ DC-11-0007 24T/kit QuantStudio 5 Real- nasal swabs, Time PCR Instrument nasopharyng Thermo Fisher For consumables QuantiVirus SARS-CoV-2 Test N, Orf1ab and eal swabs, and details of PureLink™ viral DiaCarta, Inc 12 months -25 to -15 ºC US FDA EUA kit E genes oropharynge componants refer RNA/DNA mini kit DC-11-0008 48T/kit Applied Biosystems™ al swabs, and to IFU 7500 Fast Dx Real- sputum Time PCR Instrument DC-11-0009 480T/kit For consumables ORF1ab and S and details of US FDA EUA MOL4150 Simplexa™ COVID-19 Direct 24T/kit LIAISON® MDX DiaSorin Molecular see IFU -30 to -10 ºC see IFU gene componants refer Health Canada/Interim Order to IFU 7500 Fast Dx Fast Track Diagnostics NucliSENS® Real-Time PCR For consumables 11416302 (FTD-114- Luxembourg S.á.r.l. (a ORF1ab and N and details of FTD SARS-CoV-2 96T/kit easyMAG® System Instrument see IFU -30 to -10 ºC see IFU US FDA EUA 96) Siemens Healthineers gene componants refer (bioMéreux) (Applied Company) to IFU Biosystems™) List of SARS-CoV-2 Diagnostic test kits eligible for procurement according to Board Decision GF/B42/EDP11 3/10 SARS-CoV-2 Nuclear Acid Amplification Technologies Product codes superscripted with a * (star) mark is WHO prequalified Anticipated Manufacturer Product Product Name Platform Recommended Eligibility Reference detail Manufacturer Detection type Shelf life Specimen type Comments Catalogue number (IVD product) (Extraction and amplification equipement) storage temperature WHO EUL or others (months) PCSYHF02-a 48T/kit 7500 Fast Dx QIAamp DSP Viral Real-Time PCR For consumables Fosun COVID-19 RT-PCR Fosun Pharma USA ORF1ab, and details of RNA Mini Kit Instrument 12 months -25 to -15 ºC see IFU US FDA EUA Detection Kit Inc. N and E genes componants refer (Qiagen) (Applied to IFU PCSYHF03-a 96T/kit Biosystems™) For consumables EasyScreen™ SARS-CoV-2 Genetic Signatures Ltd N-gene and E- and details of see IFU see IFU see IFU TGA Detection Kit (Australia) gene componants refer to IFU For consumables ePlex® GenMark Diagnostics, and details of EA008212 12T/kit GenMark ePlex instrument and Software see IFU 2 to 8°C see IFU US FDA EUA SARS-CoV-2 Test Inc componants refer to IFU 96T/kit 7500 Fast Dx Real-Time PCR For consumables QIAamp DSP Viral ORF1ab, and details of GS COVID-19 RT-PCR KIT Instrument GenoSensor LLC see IFU -20°C see IFU US FDA EUA RNA Mini Kit N and E genes componants refer (Applied to IFU 384T/kit Biosystems™) nasal, QuantStudio™ 3D QIAamp® DSP nasopharyng For consumables COVID-19 RT-Digital PCR Digital and details of CV0202 48T/kit Viral RNA Gnomegen LLC see IFU -10 to -30 ºC eal, and US FDA EUA Detection Kit PCR System (Applied componants refer Mini Kit (Qiagen) oropharynge Biosystems) to IFU al swab ORF1ab For consumables US FDA EUA Panther Fusion SARS-CoV-2 Region 1 and details of PRD-03455 96T/kit Panther System Hologic Inc 2 months 2 to 8°C see IFU Health Canada/Interim Order Kit ORF1ab componants refer TGA Region 2 to IFU KingFisher Flex nucleic acid Applied Biosystems For consumables Ipsum Diagnostics, and details of COV-19 IDx assay 96T/kit extraction QuantStudio12 Flex see IFU see IFU see IFU US FDA EUA LLC componants refer systems QS12 (QS12) instrument to IFU instrument 7500 Fast Dx Real- Time PCR nasopharyng instrument (Applied eal swab, QIAamp® DSP anterior For consumables Smart Detect™ SARS-CoV-2 Biosystems) InBios International, and details of COV2-E 48T/kit Viral RNA see IFU -10 to -30 ºC nasal swab US FDA EUA rRT-PCR Kit Inc componants refer Mini Kit (Qiagen) CFX96 Touch Real- and to IFU Time PCR midturbinate Detection
Load more

Recommended publications
  • Applied Biosystems 3730 and 3730Xl DNA Analyzers
    SPECIFICATION SHEET 3730 and 3730xl DNA Analyzers Applied Biosystems 3730 and 3730xl DNA Analyzers Introduction Applied Biosystems 3730 & 3730xl DNA Analyzers were developed to meet the growing needs of institutions ranging from core and research labs in academia, government, and medicine to biotechnology, pharmaceuticals, and genome centers. These high-throughput instruments couple advances in automation and optics with proprietary Applied Biosystems reagents and software to support a diverse range Key Features Key Benefits of genetic analysis projects. By • Dual-side capillary illumination • Highest-quality DNA sequencing data dramatically improving data quality, at lowest cost • Backside-thinned CCD significantly reducing total cost per – POP-7™ Polymer separation matrix sample, and enabling more runs per • Integrated auto-sampler and sample increases read length and reduces day, 3730/3730xl DNA Analyzers make plate stacker run time it quicker and easier for investigators • Onboard piercing station to get meaningful results in evolving – Multiple run modules provide options genomic applications. Whether your • Internal barcode reader for targeted length of read lab is involved in de novo sequencing, • Onboard polymer for up to 100 runs – High optical sensitivity reduces DNA resequencing, microsatellite-based and reagent consumption fragment analysis, or SNP genotyping, • Automated basecalling and quality 3730/3730xl DNA Analyzers are the value assignment – In-capillary detection consumes ideal platform for better, faster, cheaper •
    [Show full text]
  • Automated DNA Sequencing
    Automated DNA Sequencing Chemistry Guide ©Copyright 1998, The Perkin-Elmer Corporation This product is for research purposes only. ABI PRISM, MicroAmp, and Perkin-Elmer are registered trademarks of The Perkin-Elmer Corporation. ABI, ABI PRISM, Applied Biosystems, BigDye, CATALYST, PE, PE Applied Biosystems, POP, POP-4, POP-6, and Primer Express are trademarks of The Perkin-Elmer Corporation. AmpliTaq, AmpliTaq Gold, and GeneAmp are registered trademarks of Roche Molecular Systems, Inc. Centricon is a registered trademark of W. R. Grace and Co. Centri-Sep is a trademark of Princeton Separations, Inc. Long Ranger is a trademark of The FMC Corporation. Macintosh and Power Macintosh are registered trademarks of Apple Computer, Inc. pGEM is a registered trademark of Promega Corporation. Contents 1 Introduction. 1-1 New DNA Sequencing Chemistry Guide . 1-1 Introduction to Automated DNA Sequencing . 1-2 ABI PRISM Sequencing Chemistries . 1-5 PE Applied Biosystems DNA Sequencing Instruments . 1-7 Data Collection and Analysis Settings . 1-12 2 ABI PRISM DNA Sequencing Chemistries . 2-1 Overview . 2-1 Dye Terminator Cycle Sequencing Kits . 2-2 Dye Primer Cycle Sequencing Kits . 2-8 Dye Spectra . 2-12 Chemistry/Instrument/Filter Set Compatibilities . 2-13 Dye/Base Relationships for Sequencing Chemistries . 2-14 Choosing a Sequencing Chemistry. 2-15 3 Performing DNA Sequencing Reactions . 3-1 Overview . 3-1 DNA Template Preparation . 3-2 Sequencing PCR Templates . 3-10 DNA Template Quality. 3-15 DNA Template Quantity. 3-17 Primer Design and Quantitation . 3-18 Reagent and Equipment Considerations. 3-20 Preparing Cycle Sequencing Reactions . 3-21 Cycle Sequencing . 3-27 Preparing Extension Products for Electrophoresis .
    [Show full text]
  • Document Title: Development and Evaluation of a Whole Genome Amplification Method for Accurate Multiplex STR Genotyping of Compromised Forensic Casework Samples
    The author(s) shown below used Federal funds provided by the U.S. Department of Justice and prepared the following final report: Document Title: Development and Evaluation of a Whole Genome Amplification Method for Accurate Multiplex STR Genotyping of Compromised Forensic Casework Samples Author: Tracey Dawson Cruz, Ph.D. Document No.: 227501 Date Received: July 2009 Award Number: 2005-DA-BX-K002 This report has not been published by the U.S. Department of Justice. To provide better customer service, NCJRS has made this Federally- funded grant final report available electronically in addition to traditional paper copies. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. This document is a research report submitted to the U.S. Department of Justice. This report has not been published by the Department. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. FINAL TECHNICAL REPORT Development and Evaluation of a Whole Genome Amplification Method for Accurate Multiplex STR Genotyping of Compromised Forensic Casework Samples NIJ Award #: 2005-DA-BX-K002 Author: Tracey Dawson Cruz 1 This document is a research report submitted to the U.S. Department of Justice. This report has not been published by the Department. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S.
    [Show full text]
  • List of SARS-Cov-2 Diagnostic Test Kits and Equipments Eligible For
    Version 33 2021-09-24 List of SARS-CoV-2 Diagnostic test kits and equipments eligible for procurement according to Board Decision on Additional Support for Country Responses to COVID-19 (GF/B42/EDP11) The following emergency procedures established by WHO and the Regulatory Authorities of the Founding Members of the GHTF have been identified by the QA Team and will be used to determine eligibility for procurement of COVID-19 diagnostics. The product, to be considered as eligible for procurement with GF resources, shall be listed in one of the below mentioned lists: - WHO Prequalification decisions made as per the Emergency Use Listing (EUL) procedure opened to candidate in vitro diagnostics (IVDs) to detect SARS-CoV-2; - The United States Food and Drug Administration’s (USFDA) general recommendations and procedures applicable to the authorization of the emergency use of certain medical products under sections 564, 564A, and 564B of the Federal Food, Drug, and Cosmetic Act; - The decisions taken based on the Canada’s Minister of Health interim order (IO) to expedite the review of these medical devices, including test kits used to diagnose COVID-19; - The COVID-19 diagnostic tests approved by the Therapeutic Goods Administration (TGA) for inclusion on the Australian Register of Therapeutic Goods (ARTG) on the basis of the Expedited TGA assessment - The COVID-19 diagnostic tests approved by the Ministry of Health, Labour and Welfare after March 2020 with prior scientific review by the PMDA - The COVID-19 diagnostic tests listed on the French
    [Show full text]
  • Rutgers Clinical Genomics Laboratory Taqpath SARS-Cov-2 Assay EUA Summary
    Rutgers Clinical Genomics Laboratory TaqPath SARS-CoV-2 Assay EUA Summary ACCELERATED EMERGENCY USE AUTHORIZATION (EUA) SUMMARY SARS-CoV-2 ASSAY (Rutgers Clinical Genomics Laboratory) For in vitro diagnostic use Rx only For use under Emergency Use Authorization (EUA) Only (The Rutgers Clinical Genomics Laboratory TaqPath SARS-CoV-2 Assay will be performed in the Rutgers Clinical Genomics Laboratory, a Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a certified high-complexity laboratory, per the Instructions for Use that were reviewed by the FDA under this EUA). INTENDED USE The Rutgers Clinical Genomics Laboratory TaqPath SARS-CoV-2 Assay is a real-time reverse transcription polymerase chain reaction (rRT-PCR) test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in oropharyngeal (throat) swab, nasopharyngeal swab, anterior nasal swab, mid-turbinate nasal swab, and bronchoalveolar lavage (BAL) fluid from individuals suspected of COVID-19 by their healthcare provider. This test is also for use with saliva specimens that are self-collected at home or in a healthcare setting by individuals using the Spectrum Solutions LLC SDNA-1000 Saliva Collection Device when determined to be appropriate by a healthcare provider. Testing is limited to Rutgers Clinical Genomics Laboratory (RCGL) at RUCDR Infinite Biologics – Rutgers University, Piscataway, NJ, that is a Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a certified high-complexity laboratory. Results are for the detection and identification of SARS-CoV-2 RNA. The SARS- CoV-2 RNA is generally detectable in respiratory specimens during the acute phase of infection.
    [Show full text]
  • DNA Fragment Analysis by Capillary Electrophoresis User Guide
    USER GUIDE DNA Fragment Analysis by Capillary Electrophoresis Publication Number 4474504 Revision B For Research Use Only. Not intended for use in diagnostic procedures. For Research Use Only. Not intended for use in diagnostic procedures. The information in this guide is subject to change without notice. DISCLAIMER LIFE TECHNOLOGIES CORPORATION AND/OR ITS AFFILIATE(S) DISCLAIM ALL WARRANTIES WITH RESPECT TO THIS DOCUMENT, EXPRESSED OR IMPLIED, INCLUDING BUT NOT LIMITED TO THOSE OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT. TO THE EXTENT ALLOWED BY LAW, IN NO EVENT SHALL LIFE TECHNOLOGIES AND/OR ITS AFFILIATE(S) BE LIABLE, WHETHER IN CONTRACT, TORT, WARRANTY, OR UNDER ANY STATUTE OR ON ANY OTHER BASIS FOR SPECIAL, INCIDENTAL, INDIRECT, PUNITIVE, MULTIPLE OR CONSEQUENTIAL DAMAGES IN CONNECTION WITH OR ARISING FROM THIS DOCUMENT, INCLUDING BUT NOT LIMITED TO THE USE THEREOF. TRADEMARKS All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified. AmpErase, AmpliTaq, AmpliTaq Gold, and TaqMan are registered trademarks of Roche Molecular Systems, Inc. AFLP is a registered trademark of Keygene N.V. Millipore is a registered trademark of Merck KGaA. © 2014 Thermo Fisher Scientific Inc. All rights reserved. Contents About This Guide . 13 Revision history . 13 Purpose . 13 Prerequisites . 13 Structure of this guide . 14 ■ CHAPTER 1 Introduction to Fragment Analysis . 15 Fragment analysis versus sequencing…what is the difference? . 15 Fragment analysis . 15 Sequencing . 16 What can I do with fragment analysis? . 16 Types of applications . 16 Applications described in this guide . 17 What is capillary electrophoresis? . 18 Fragment analysis workflow . 19 ■ CHAPTER 2 Experimental Design .
    [Show full text]
  • Supporting Information Supplementary Methods
    Supporting Information Supplementary methods This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix to: Caly L, Druce J, Roberts J, et al. Isolation and rapid sharing of the 2019 novel coronavirus (SAR-CoV-2) from the first patient diagnosed with COVID-19 in Australia. Med J Aust 2020; doi: 10.5694/mja2.50569. Supplementary methods 1.1 Generation of SARS-CoV-2 cDNA 200μL aliquots from swab (nasopharyngeal in VTM), sputum, urine, faeces and serum samples were subjected to RNA extraction using the QIAamp 96 Virus QIAcube HT Kit (Qiagen, Hilden, Germany) and eluted in 60μL. Reverse transcription was performed using the BioLine SensiFAST cDNA kit (Bioline, London, United Kingdom), total reaction mixture (20μL), containing 10μL RNA extract, 4μL 5x TransAmp buffer, 1μL reverse transcriptase and 5μL nuclease-free water. The reactions were incubated at 25°C for 10 min, 42°C for 15 min and 85°C for 5 min. 1.2 Nested SARS-CoV-2 RT-PCR and Sanger sequencing A PCR mixture containing 2μL cDNA, 1.6 μl 25mM MgCl2, 4μL 10x Qiagen Taq Buffer, 0.4μL 20mM dNTPs, 0.3μL Taq polymerase (Qiagen, Hilden, Germany) and 2μL of 10 μM primer pools as described2. Briefly, first round included the forward (5'-GGKTGGGAYTAYCCKAARTG-3') and reverse (5'-GGKTGGGAYTAYCCKAARTG-3') primers. Cycling conditions were 94°C for 10min, followed by 30 cycles of 94°C for 30s, 48°C for 30s and 72°C for 40s, with a final extension of 72°C for 10 min.
    [Show full text]
  • Applied Biosystems 3130 and 3130Xl Genetic Analyzers
    System Profile Applied Biosystems 3130 and 3130xl Genetic Analyzers. System Profile Applied Biosystems 3130 and 3130xl Genetic Analyzers Table of Contents A Powerful Blend of Flexibility and Performance 1 Ease-of-Use 1 Key Features 2 Capillary Electrophoresis 2 Automated Polymer Delivery System 2 Enhanced Thermal Control 2 High-Perfomance Capillaries and Electro-osmotic Flow Suppression (EOF) Polymers 2 Detection Method Designed for Sensitivity 3 Spectral Array Detection 3 Application Flexibility 4 Complete System Optimized for Multiple Applications 4 One Polymer, One Array, Maximum Performance 4 System Software Suite 5 Results 6 Summary 9 References 10 www.appliedbiosystems.com 16-capillary 3130xl Genetic Analyzer: High-performance workhorse. With 16-capillary throughput and advanced automation capabilities, the 3130xl system is flexible enough to meet the throughput needs of the busiest core facility or research group. The streamlined set-up and 24-hour unattended operation make it an ideal choice for low or medium throughput laboratories. Ease-of-Use Complete automation. At every scale, Applied Biosystems genetic analyzers are known for their advanced automation and “hands-free” operation. The Automated Polymer Delivery System A Powerful Blend of Flexibility and Performance eliminates manual washing and filling of polymer syringes, Applied Biosystems has a long tradition of providing significantly reducing the time required for instrument set- excellence in life science instruments, reagents, and software. up and maintenance. All steps are automated, including This tradition of pioneering and innovation in the field polymer loading, sample injection, separation and detection, of genetic analysis continues with the introduction of and data analysis. After placing plates on the autosampler Applied Biosystems next-generation systems, the 3130 and importing sample information, just select the “Start and 3130xl Genetic Analyzers.
    [Show full text]
  • Polymerase Chain Reaction Assay for Detection and Identity of Extraneous Chicken Anemia Virus (CAV)
    VIRPRO0118.05 Page 1 of 13 United States Department of Agriculture Center for Veterinary Biologics Testing Protocol Polymerase Chain Reaction Assay for Detection and Identity of Extraneous Chicken Anemia Virus (CAV) Date: September 25, 2014 Number: VIRPRO0118.05 Supersedes: VIRPRO0118.04, June 28, 2011 Contact: Sandra K. Conrad, (515) 337-7200 Danielle M. Koski Approvals: /s/Geetha B. Srinivas Date: 13Nov14 Geetha B. Srinivas, Section Leader Virology /s/Rebecca L.W. Hyde Date: 18Nov14 Rebecca L.W. Hyde, Section Leader Quality Management Center for Veterinary Biologics United States Department of Agriculture Animal and Plant Health Inspection Service P. O. Box 844 Ames, IA 50010 Mention of trademark or proprietary product does not constitute a guarantee or warranty of the product by USDA and does not imply its approval to the exclusion of other products that may be suitable. UNCONTROLLED COPY Center for Veterinary Biologics VIRPRO0118.05 Testing Protocol Page 2 of 13 Polymerase Chain Reaction Assay for Detection and Identity of Extraneous Chicken Anemia Virus (CAV) Table of Contents 1. Introduction 2. Materials 2.1 Equipment/instrumentation 2.2 Reagents/supplies 3. Preparation for the Test 3.1 Personnel qualifications/training 3.2 Preparation of equipment/instrumentation 3.3 Preparation of reagents/control procedures 3.4 Storage of the sample 4. Performance of the Test 4.1 DNA extraction 4.2 Amplification of CAV DNA 4.3 Analysis of amplified CAV DNA 5. Interpretation of the Test Results 6. Report of Test Results 7. Summary of Revisions UNCONTROLLED COPY Center for Veterinary Biologics VIRPRO0118.05 Testing Protocol Page 3 of 13 Polymerase Chain Reaction Assay for Detection and Identity of Extraneous Chicken Anemia Virus (CAV) 1.
    [Show full text]
  • Brochure: Biotech Essentials
    High-performance, flexible and reliable products that will set you up for success thermofisher.com/biotechessentials Techniques like cell growth, modification and analysis, sample preparation, PCR, qPCR, sequencing, electrophoresis and western blotting are the building blocks of your projects. Getting these fundamentals right first-time is critical to you moving quickly and efficiently towards your end goal. In order to do this, you need a partner who can supply all the right products and services. They need to be reliable, flexible, scalable and save you time so that you can minimise development and product costs, reduce risk, and reach your next milestone faster. We have a whole range of solutions dedicated to serving these needs ranging from off-the-shelf and customisable reagents and instruments to outsourcing services and manufacturing solutions. Take a look through this brochure to find out more. We’ll work with you every step of the way to ensure you’re set for success. Cell growth, scale-up and modification 4 Cellular analysis 6 Cellular analysis screening 8 Sample preparation 10 Synthetic biology 12 PCR 14 Electrophoresis 16 RNA extraction and cDNA synthesis for qPCR 17 Real-time PCR 18 Sanger and next-generation sequencing 20 Protein analysis 22 Outsourcing services 25 Custom manufacturing and commercial supply 26 Opening a new lab or relocating? 28 3 Cell Growth, Scale-up and Modification Whether you are culturing or modifying your cells, our range of Gibco™, Thermo Scientific™ Nunc™ and Invitrogen™ products will deliver the quality, consistency and performance you need at every step of your journey from discovery to commercialisation.
    [Show full text]
  • Relative Quantification Getting Started Guide for the Applied Biosystems 7300/7500/7500 Fast Real-Time PCR System RQ Experiment Workflow
    Getting Started Guide Relative Quantification Introduction and Example Applied Biosystems 7300/7500/7500 Fast RQ Experiment Real-Time PCR System Designing an RQ Experiment Performing Primer Extended on mRNA 5′ 3′ 5′ cDNA Reverse Primer Oligo d(T) or random hexamer Reverse Synthesis of 1st cDNA strand 3′ 5′ cDNA Transcription Generating Data from STANDARD RQ Plates - Standard Generating Data from FAST RQ Plates - Fast System Generating Data in an RQ Study © Copyright 2004, Applied Biosystems. All rights reserved. For Research Use Only. Not for use in diagnostic procedures. Authorized Thermal Cycler This instrument is an Authorized Thermal Cycler. Its purchase price includes the up-front fee component of a license under United States Patent Nos. 4,683,195, 4,683,202 and 4,965,188, owned by Roche Molecular Systems, Inc., and under corresponding claims in patents outside the United States, owned by F. Hoffmann-La Roche Ltd, covering the Polymerase Chain Reaction ("PCR") process to practice the PCR process for internal research and development using this instrument. The running royalty component of that license may be purchased from Applied Biosystems or obtained by purchasing Authorized Reagents. This instrument is also an Authorized Thermal Cycler for use with applications licenses available from Applied Biosystems. Its use with Authorized Reagents also provides a limited PCR license in accordance with the label rights accompanying such reagents. Purchase of this product does not itself convey to the purchaser a complete license or right to perform the PCR process. Further information on purchasing licenses to practice the PCR process may be obtained by contacting the Director of Licensing at Applied Biosystems, 850 Lincoln Centre Drive, Foster City, California 94404.
    [Show full text]
  • Real-Time Fluorescent RT-PCR Kit for Detecting SARS-Cov-2
    Real-Time Fluorescent RT-PCR Kit for Detecting SARS-CoV-2 For Emergency Use Only Instructions for Use (50 reactions/kit) For in vitro Diagnostic (IVD) Use Rx Only Labeling Revised: January XX, 2021 BGI Genomics Co. Ltd. (“BGI”) Building No. 7, BGI Park No. 21 Hongan 3rd Street Yantian District, Shenzhen, 518083 China, (+86) 400-706-6615 1 Table of Contents Table of Contents ................................................................................................................... 2 Intended Use ......................................................................................................................... 3 Summary and Explanation ....................................................................................................... 4 Principles and Procedure ......................................................................................................... 5 Materials Provided ................................................................................................................. 6 Materials and Equipment Required But Not Provided .................................................................. 7 Warnings and Precautions........................................................................................................ 8 Reagent Storage, Handling, and Stability ..................................................................................11 Specimen Collection, Storage, and Transfer ..............................................................................12 Laboratory Procedures ...........................................................................................................13
    [Show full text]